Evidence map›Paper›PMID 25505122›Full record

ArticlemBio2014

Moratorium on research intended to create novel potential pandemic pathogens.

Marc Lipsitch, Thomas V Inglesby

Erratum issuedAbstract readEditorial
In one paragraph

Article in mBio, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Understanding biosafety practitioner perspectives.Politics and the life sciences : the journal of the Association for Politics and the Life Sciences · 2026
    Article
  2. Article
  3. Review
  4. Future pandemics and the urge to 'do something'.Journal of medical ethics · 2025
    Article
  5. Biosafety, biosecurity, and bioethics.Monash bioethics review · 2024
    Review
  6. Public role in research oversight.Journal of virology · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Why Do Exceptionally Dangerous Gain-of-Function Experiments in Influenza?Methods in molecular biology (Clifton, N.J.) · 2018
    Review
  18. Article
  19. Underprotection of Unpredictable Statistical Lives Compared to Predictable Ones.Risk analysis : an official publication of the Society for Risk Analysis · 2017
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Marc LipsitchDepartment of Epidemiology, Center for Communicable Disease Dynamics, Harvard School of Public Health, Boston, Massachusetts, USA mlipsitc@hsph.harvard.edu tinglesby@upmc.edu.
Thomas V InglesbyUPMC Center for Health Security, Baltimore, Maryland, USA mlipsitc@hsph.harvard.edu tinglesby@upmc.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biomedical ResearchCapital FinancingContainment of BiohazardsHealth PolicyInfluenza A virusMiddle East Respiratory Syndrome CoronavirusOccupational DiseasesOccupational HealthPandemicsRisk AssessmentSevere acute respiratory syndrome-related coronavirusUnited StatesVirus Diseases

Identifiers

PMID25505122
PMCPMC4271556

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.